Unknown

Dataset Information

0

Emergence of diversity in carbapenemase-producing Escherichia coli ST131, England, January 2014 to June 2016.


ABSTRACT: BackgroundEscherichia coli ST131, a global, high-risk clone, comprises fluoroquinolone resistance (FQ-R) mutations and CTX-M extended-spectrum beta-lactamases associated with the fimH30-encoding clades, C1 and C2. Further carbapenem resistance development in ST131 is a public health concern.AimThis observational study aimed to probe the diversity of carbapenemase-producing E. coli (CP E. coli) ST131 across England.MethodsST131 isolates were identified using whole-genome sequencing (WGS) data generated for all non-duplicate CP E. coli from human samples submitted to the national reference laboratory from January 2014 to June 2016. Antimicrobial resistance (AMR) gene content and single nucleotide polymorphism (SNP) data were compared against a published ST131 phylogeny and analysed alongside patient metadata.ResultsThirty-nine genetically diverse ST131 CP E. coli, from eight of nine regions, represented 10% of CP E. coli isolates sequenced. Ten and eight isolates were from the FQ-susceptible (FQ-S) clades A and B, while eight and 15 isolates belonged to the FQ-R clades C1 or C2, respectively. Seven distinct carbapenemases were identified: KPC-2 (21 isolates, 6 regions) frequently occurred among clade C2 isolates (n?=?10). OXA-48-producers (10 isolates, 3 regions) were often from clade A (n?=?5). NDM-1 (n?=?4), NDM-5 (n?=?1), VIM-1 (n?=?1), VIM-4 (n?=?1) and OXA-181 (n?=?1) were also identified. Clade C2 isolates encoded more AMR genes than those from clades A (p?=?0.02), B (p?=?9.6 x 10-3) or C1 (p?=?0.03).ConclusionWhen compared with its global predominance among ESBL-E. coli, ST131 represented a fraction of the CP E. coli received, belonging to diverse clades and encoding diverse carbapenemases. The greater accumulation of resistance genes in clade C2 isolates highlights the need for ongoing monitoring of this high-risk lineage.

SUBMITTER: Ellaby N 

PROVIDER: S-EPMC6749775 | biostudies-literature | 2019 Sep

REPOSITORIES: biostudies-literature

altmetric image

Publications

Emergence of diversity in carbapenemase-producing <i>Escherichia coli</i> ST131, England, January 2014 to June 2016.

Ellaby Nicholas N   Doumith Michel M   Hopkins Katie L KL   Woodford Neil N   Ellington Matthew J MJ  

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 20190901 37


Background<i>Escherichia coli</i> ST131, a global, high-risk clone, comprises fluoroquinolone resistance (FQ-R) mutations and CTX-M extended-spectrum beta-lactamases associated with the <i>fimH</i>30-encoding clades, C1 and C2. Further carbapenem resistance development in ST131 is a public health concern.AimThis observational study aimed to probe the diversity of carbapenemase-producing <i>E. coli</i> (CP <i>E. coli</i>) ST131 across England.MethodsST131 isolates were identified using whole-geno  ...[more]

Similar Datasets

| S-EPMC4214325 | biostudies-literature
| PRJEB32306 | ENA
| S-EPMC6167611 | biostudies-literature
| S-EPMC5718389 | biostudies-literature
| S-EPMC4073846 | biostudies-literature
| S-EPMC8110189 | biostudies-literature
| S-EPMC3910876 | biostudies-literature
| S-EPMC4500775 | biostudies-literature
| S-EPMC8106709 | biostudies-literature
| S-EPMC3491773 | biostudies-literature